Listed

Beam Therapeutics Inc.: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Aug 10, 2021 and accepted by EDGAR at Aug 10, 2021, 07:46 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-04-01 to 2021-06-30$6.0kus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2021-01-01 to 2021-06-30$12.0kus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2021-04-01 to 2021-06-30$45.6mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-01-01 to 2021-06-30$235.7mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-04-01 to 2021-06-30−$59.0mus-gaap:OperatingIncomeLoss
Operating income6 months2021-01-01 to 2021-06-30−$259.3mus-gaap:OperatingIncomeLoss
Net income3 months2021-04-01 to 2021-06-30−$76.3mus-gaap:NetIncomeLoss
Net income6 months2021-01-01 to 2021-06-30−$277.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-04-01 to 2021-06-30−$1.23us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2021-01-01 to 2021-06-30−$4.54us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-04-01 to 2021-06-30−$1.23us-gaap:EarningsPerShareBasic
Basic EPS6 months2021-01-01 to 2021-06-30−$4.54us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-04-01 to 2021-06-3062,210,239 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2021-01-01 to 2021-06-3061,215,705 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2021-01-01 to 2021-06-30−$71.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2021-01-01 to 2021-06-30$27.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-06-30$212.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-06-30$678.0mus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$893.1mus-gaap:Assets
Current liabilitiesAt period end2021-06-30$128.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-06-30$344.5mus-gaap:Liabilities
Shareholders' equityAt period end2021-06-30$548.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000950170-21-001110. Last ingested by Listed: Nov 14, 2026, 12:58 ET. Listed shows no prices and gives no investment advice.